Combination immunotherapy as a non-chemotherapy alternative for refractory or recurrent CNS lymphoma

被引：35

作者：

Ambady, Prakash ^{[1
]}

Szidonya, Laszlo ^{[1
]}

Firkins, Jenny ^{[1
]}

James, Jessica ^{[1
]}

Johansson, Kirsten ^{[1
]}

White, Tricia ^{[1
]}

Jezierski, Caroline ^{[1
]}

Doolittle, Nancy D. ^{[1
]}

Neuwelt, Edward A. ^{[1
,2
]}

机构：

[1] Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,L603, Portland, OR 97201 USA

[2] Portland VA Med Ctr, Dept Neurosurg, Portland, OR USA

来源：

LEUKEMIA & LYMPHOMA | 2019年 / 60卷 / 02期

关键词：

CENTRAL-NERVOUS-SYSTEM; STEM-CELL RESCUE; THIOTEPA; RELAPSE;

D O I：

10.1080/10428194.2018.1480771

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：515 / 518

页数：4

共 14 条

[1] Patterns of relapse in primary central nervous system lymphoma: inferences regarding the role of the neuro-vascular unit and monoclonal antibodies in treating occult CNS disease [J].

Ambady, Prakash ;

Fu, Rongwei ;

Netto, Joao Prola ;

Kersch, Cymon ;

Firkins, Jenny ;

Doolittle, Nancy D. ;

Neuwelt, Edward A. .

FLUIDS AND BARRIERS OF THE CNS, 2017, 14

[2]

Ambady Prakash, 2015, CNS Oncol, V4, P393, DOI 10.2217/cns.15.34

[3] Programmed Death Ligand 1 Is Expressed by Non-Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells [J].

Andorsky, David J. ;

Yamada, Reiko E. ;

Said, Jonathan ;

Pinkus, Geraldine S. ;

Betting, David J. ;

Timmerman, John M. .

CLINICAL CANCER RESEARCH, 2011, 17 (13) :4232-4244

[4] Cognitive functions in primary CNS lymphoma after single or combined modality regimens [J].

Correa, Denise D. ;

Shi, Weiji ;

Abrey, Lauren E. ;

DeAngelis, Lisa M. ;

Omuro, Antonio M. ;

Deutsch, Mariel B. ;

Thaler, Howard T. .

NEURO-ONCOLOGY, 2012, 14 (01) :101-108

[5] Autologous Stem Cell Transplantation with Thiotepa, Busulfan, and Cyclophosphamide (TBC) Conditioning in Patients with CNS Involvement by Non-Hodgkin Lymphoma [J].

Cote, Gregory M. ;

Hochberg, Ephraim P. ;

Muzikansky, Alona ;

Hochberg, Fred H. ;

Drappatz, Jan ;

McAfee, Steven L. ;

Batchelor, Tracy T. ;

LaCasce, Ann S. ;

Fisher, David C. ;

Abramson, Jeremy S. ;

Armand, Philippe ;

Chen, Yi-Bin .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (01) :76-83

[6] Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial [J].

Ferreri, Andres J. M. ;

Cwynarski, Kate ;

Pulczynski, Elko ;

Ponzoni, Mourilio ;

Deckert, Martina ;

Politi, Letterio S. ;

Torri, Valter ;

Fox, Christopher P. ;

La Rosee, Paul ;

Schorb, Elisabeth ;

Ambrosetti, Achille ;

Roth, Alexander ;

Hemmoway, Claire ;

Ferrari, Angela ;

Linton, Kim M. ;

Ruda, Roberta ;

Binder, Mascha ;

Pukrop, Tobias ;

Balzarotti, Monica ;

Fabbri, Alberto ;

Johnson, Peter ;

Gorlov, Jette Sonderskov ;

Hess, Georg ;

Panse, Jens ;

Pisani, Francesco ;

Tucci, Alessandra ;

Stilgenbauer, Stephan ;

Hertenstein, Bernd ;

Keller, Ulrich ;

Krause, Stefan W. ;

Levis, Alessandro ;

Schmoll, Hans J. ;

Covalli, Franco ;

Finke, Jurgen ;

Reni, Michele ;

Zucca, Emanuele ;

Illerhaus, Gerald .

LANCET HAEMATOLOGY, 2016, 3 (05) :E217-E227

[7] Most primary central nervous system diffuse large B-cell lymphomas occurring in immunocompetent individuals belong to the nongerminal center subtype: a retrospective analysis of 31 cases [J].

Hattab, Eyas M. ;

Martin, Sarah E. ;

Al-Khatib, Sohaib M. ;

Kupsky, William J. ;

Vance, Gail H. ;

Stohler, Ryan A. ;

Czader, Magdalena ;

Al-Abbadi, Mousa A. .

MODERN PATHOLOGY, 2010, 23 (02) :235-243

[8]

Jacoline B, 2018, BLOOD, V130, P582

[9] Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors [J].

Jahnke, Kristoph ;

Thiel, Eckhard ;

Martus, Peter ;

Herrlinger, Ulrich ;

Weller, Michael ;

Fischer, Lars ;

Korfel, Agnieszka .

JOURNAL OF NEURO-ONCOLOGY, 2006, 80 (02) :159-165

[10]

Kohrt HE, 2012, IMMUNOTHERAPY-UK, V4, P511, DOI [10.2217/IMT.12.38, 10.2217/imt.12.38]

← 1 2 →